Arcadia Accounts Payable from 2010 to 2024

RKDA Stock  USD 6.30  0.21  3.45%   
Arcadia Biosciences' Accounts Payable is increasing over the years with slightly volatile fluctuation. Overall, Accounts Payable is expected to go to about 970.9 K this year. Accounts Payable is the amount Arcadia Biosciences owes to suppliers or vendors for products or services received but not yet paid for. It represents Arcadia Biosciences' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2012-12-31
Previous Quarter
1.6 M
Current Value
1.7 M
Quarterly Volatility
1.7 M
 
Yuan Drop
 
Covid
Check Arcadia Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcadia Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 501.1 K, Interest Expense of 247.1 K or Selling General Administrative of 14.7 M, as well as many indicators such as Price To Sales Ratio of 0.69, Dividend Yield of 0.0018 or PTB Ratio of 0.32. Arcadia financial statements analysis is a perfect complement when working with Arcadia Biosciences Valuation or Volatility modules.
  
Check out the analysis of Arcadia Biosciences Correlation against competitors.
For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.

Latest Arcadia Biosciences' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Arcadia Biosciences over the last few years. An accounting item on the balance sheet that represents Arcadia Biosciences obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Arcadia Biosciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Arcadia Biosciences' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcadia Biosciences' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Arcadia Accounts Payable Regression Statistics

Arithmetic Mean789,129
Geometric Mean494,044
Coefficient Of Variation101.81
Mean Deviation589,488
Median492,000
Standard Deviation803,429
Sample Variance645.5B
Range2.5M
R-Value0.37
Mean Square Error601.8B
R-Squared0.13
Significance0.18
Slope65,830
Total Sum of Squares9T

Arcadia Accounts Payable History

2024970.9 K
2023801 K
2022905 K
20211.4 M
2020726 K
2019492 K
20182.6 M

About Arcadia Biosciences Financial Statements

Arcadia Biosciences stakeholders use historical fundamental indicators, such as Arcadia Biosciences' Accounts Payable, to determine how well the company is positioned to perform in the future. Although Arcadia Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Arcadia Biosciences' assets and liabilities are reflected in the revenues and expenses on Arcadia Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Arcadia Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable801 K970.9 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Arcadia Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arcadia Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arcadia Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arcadia Biosciences Stock:
Check out the analysis of Arcadia Biosciences Correlation against competitors.
For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Agricultural Products & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. If investors know Arcadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcadia Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.285
Earnings Share
(6.77)
Revenue Per Share
3.802
Quarterly Revenue Growth
(0.04)
Return On Assets
(0.39)
The market value of Arcadia Biosciences is measured differently than its book value, which is the value of Arcadia that is recorded on the company's balance sheet. Investors also form their own opinion of Arcadia Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcadia Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcadia Biosciences' market value can be influenced by many factors that don't directly affect Arcadia Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcadia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcadia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcadia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.